HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC25A17
solute carrier family 25 member 17
Chromosome 22 · 22q13.2
NCBI Gene: 10478Ensembl: ENSG00000100372.15HGNC: HGNC:10987UniProt: B4DP73
45PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
peroxisomal membranenucleotide transmembrane transportprotein bindingADP transmembrane transporter activityneurodegenerative diseaseCOVID-19severe acute respiratory syndromeuterine fibroid
✦AI Summary

SLC25A17 (solute carrier family 25 member 17), also known as PMP34, is a peroxisomal membrane transporter that mediates cofactor import essential for peroxisomal metabolism. The protein functions as a counter-exchanger, transporting free coenzyme A (CoA), flavin adenine dinucleotide (FAD), and nicotinamide adenine dinucleotide (NAD+) from the cytosol into the peroxisomal matrix in exchange for intraperoxisomally generated adenosine 3',5'-diphosphate (PAP), flavin mononucleotide (FMN), and adenosine monophosphate (AMP) 1. The transporter also facilitates transport of adenosine diphosphate (ADP) and other cofactors at lower efficiency 1. SLC25A17 maintains peroxisomal redox homeostasis by regulating glutathione and NAD(P)H metabolism across the peroxisomal membrane 2. While knockout mice lacking functional SLC25A17 show minimal phenotype under standard conditions, they display hepatomegaly and impaired phytanic and pristanic acid degradation upon dietary phytol challenge, indicating specialized roles in branched fatty acid metabolism 3. Clinically, elevated SLC25A17 expression correlates with poor prognosis in head and neck squamous cell carcinoma and prostate cancer, where it promotes drug resistance through metabolic reprogramming 45. Additionally, SLC25A17 genetic variants associate with Alzheimer's disease risk through effects on hippocampal mitochondrial function 6.

Sources cited
1
SLC25A17 is a peroxisomal transporter of CoA, FAD, NAD+, FMN, AMP, and to lesser extent PAP and ADP; functions by counter-exchange mechanism
PMID: 22185573
2
SLC25A17 sustains peroxisomal redox homeostasis by regulating glutathione and NAD(P)H metabolism
PMID: 38159891
3
SLC25A17 knockout mice show impaired phytanic and pristanic acid degradation upon dietary phytol administration but normal functioning of other peroxisomal pathways
PMID: 32266253
4
SLC25A17 promotes enzalutamide resistance in prostate cancer through metabolic reprogramming affecting fatty acid and lipid metabolism
PMID: 34939235
5
High SLC25A17 expression in head and neck squamous cell carcinoma associates with worse prognosis and reduced immunotherapeutic response
PMID: 37386359
6
SLC25A17 is identified as an Alzheimer's disease susceptibility gene through transcriptome-wide association study
PMID: 38858380
7
SLC25A17 (PMP34) is mentioned in context of peroxisomal protein import machinery and quality control
PMID: 36541703
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.33Weak
COVID-19Open Targets
0.26Weak
severe acute respiratory syndromeOpen Targets
0.25Weak
uterine fibroidOpen Targets
0.11Weak
head and neck squamous cell carcinomaOpen Targets
0.08Suggestive
triple-negative breast cancerOpen Targets
0.07Suggestive
bipolar disorderOpen Targets
0.07Suggestive
glycine N-methyltransferase deficiencyOpen Targets
0.05Suggestive
hepatocellular adenomaOpen Targets
0.05Suggestive
hepatocellular carcinomaOpen Targets
0.05Suggestive
galactosemia 4Open Targets
0.05Suggestive
Congenital bile acid synthesis defect type 1Open Targets
0.05Suggestive
non-alcoholic fatty liver diseaseOpen Targets
0.05Suggestive
mathematical abilityOpen Targets
0.05Suggestive
congenital disorder of glycosylation type IIOpen Targets
0.05Suggestive
portal hypertensionOpen Targets
0.04Suggestive
congenital disorder of glycosylation type IOpen Targets
0.04Suggestive
infantile hypertrophic cardiomyopathy due to MRPL44 deficiencyOpen Targets
0.04Suggestive
transient infantile hypertriglyceridemia and hepatosteatosisOpen Targets
0.04Suggestive
complement component C1s deficiencyOpen Targets
0.04Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
MTCH1Protein interaction90%MTCH2Protein interaction85%ABCD1Protein interaction76%PEX12Protein interaction76%PEX13Protein interaction76%PEX19Protein interaction76%
Tissue Expression6 tissues
Ovary
100%
Liver
64%
Brain
57%
Bone Marrow
36%
Lung
31%
Heart
20%
Gene Interaction Network
Click a node to explore
SLC25A17MTCH1MTCH2ABCD1PEX12PEX13PEX19
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt O43808
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.90LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.60 [0.41–0.90]
RankingsWhere SLC25A17 stands among ~20K protein-coding genes
  • #9,519of 20,598
    Most Researched45
  • #8,108of 17,882
    Most Constrained (LOEUF)0.90
Genes detectedSLC25A17
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
PEX13 prevents pexophagy by regulating ubiquitinated PEX5 and peroxisomal ROS.
PMID: 36541703
Autophagy · 2023
1.00
2
The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme A, FAD and NAD+.
PMID: 22185573
Biochem J · 2012
0.90
3
PMID: 32266253
Front Cell Dev Biol · 2020
0.80
4
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration-resistant prostate cancer.
PMID: 34939235
Mol Carcinog · 2022
0.70
5
The solute carrier SLC25A17 sustains peroxisomal redox homeostasis in diverse mammalian cell lines.
PMID: 38159891
Free Radic Biol Med · 2024
0.60